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A hidden cost lurks behind the sweetener in your morning
coffee, the paint on your living room walls, perhaps even the soap
you use to wash your hands.
At some point in their development, these products or their
raw ingredients may have been applied to the eyes or skin of live
animals, injected into their bodies, or pumped into their stomachs
or airways. In tests of potential carcinogens, subjects are given a
substance every day for two years; other tests involve killing preg-
nant animals and studying the fetuses.
Governments in most developed countries require a battery
of experiments on materials including food additives, drugs and
vaccines, pesticides, andmany other chemicals. The results may be
used to ban potential toxins, formulate standards to protect
workers who handle them, warn certain classes of people such as
pregnant women against taking a drug, or create packaging labels
to let consumers know what to do if, for example, the product
splashes into their eyes.
But the real-life applications for some tested substances are
as trivial as an“improved” laundry detergent, a new eye shadow, or
a copycat drug to replace a profitable pharmaceutical whose patent
has expired.
No one knows exactly howmany animals suffer each year for
toxicity testing, but the annual toll is likely in the millions in the
U.S. alone. Each test consumes dozens to thousands of animals
apiece, says Troy Seidle, Humane Society International director
for research and toxicology; registration of a single pesticide re-
quires more than 50 experiments and the use of as many as 12,000
animals.
But recent years have brought a growing recognition among
scientists and government officials that the welfare of animals in
laboratories matters to the public, that animal tests often don’t pre-
dict effects in people, and that they are simply too inefficient to
meet the high demand for chemical testing. These changes have
spurred a revolution that is moving the field toward tests per-
formed in computer simulations and modern-day petri dishes—
developments that could spell the end of animal use in toxicology
within two decades.
In conducting conventional animal tests, says Martin
Stephens, HSUS vice president of animal research issues, “you
don’t have to know a lot about animals’ biology; you hope that it’s
similar to our own and you just do the test.Whereas now we know
a lot more about human and animal biology, and we can model
things in the test tube that we couldn’t necessarily do 50 years ago.”
The old methods are “basically using animals as surrogate
people,” he says. “We can do better.”
SUFFERING FOR SHAKY SCIENCE
In addition to the often severe suffering inflicted during safety tests,
which are almost always conducted without pain relief,
animals used in toxicity testing suffer mental and emotional
stress from repeated, often rough handling and nearly constant
confinement.
While rabbits, guinea pigs, dogs, birds, and fish are used in
toxicity testing, rats andmice are the mammalian species most fre-
quently experimented on—yet these rodents are exempted from
even the modest provisions of the Animal Welfare Act, and facili-
ties are not required to report how many they use.
Chosen for their small size, high reproduction rate, and
relatively docile nature, rats and mice are too often perceived as
content in a lab setting; many people mistakenly think the need
for a natural environment has been bred out of them, says
Stephens. But several years ago, a film documenting rats taken
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from a lab and put in an enclosed natural
area revealed something different: They im-
mediately began digging burrows, building
nests, and creating their own society.
“There’s a sense that these animals
don’t quite experience the suffering that
other animals can experience. Partly it has
something to do with their small size, and
it has something to do with their stoic de-
meanor,” says Stephens, noting that rodents
have evolved behaviors to hide weaknesses
from predators.“They’re not like dogs, who
will let you know what’s going on. So it’s
especially sad that these are the animals who
are used the most in the lab—because they
are the hardest to figure out when they’re in
pain or distress.”
It’s too easy for a researcher to glance
into a cage, see a quiet mouse huddled in
the corner, andmove on—especially during
the day, when these nocturnal animals are
resting, says Stephens. But to those willing
to pay attention, the signs are there. Dis-
tressed rodents may be hunched over with a
disheveled appearance, says Seidle. Or they
may be highly agitated and hyperactive,
exhibiting repetitive behaviors such as
running in circles or climbing the walls of
their shoebox-sized cages.
When the tests are over—after up to
two years in some studies—rodents are
decapitated by mini-guillotines or have
their necks broken. Many are gassed to
death with carbon dioxide, a method that’s
been shown to be distressful.
Animal testing has historically been a
“health-crisis-driven enterprise,” Stephens
says. In the 1930s, a toxin in a mascara
product caused blindness in women
and one death, leading to the de-
velopment of eye irritation tests
on rabbits. In the 1950s and
1960s, birth defects in babies
born to pregnant women who
took the drug thalidomide trig-
gered new requirements for wide-
spread reproductive toxicity testing in
animals. And concern about pesticides
resulted in the creation of a laundry list of
required animal tests in the 1970s and ’80s.
Fear of toxins in products and the environ-
ment, combined with the development of
lifesaving substances such as penicillin and
the polio vaccine, has led to entrenched
support of animal testing among many sci-
entists and government regulators.
But numerous prominent failures over
the decades have underscored the weak-
nesses of animal tests. Results can vary from
lab to lab and species to species. Seidle
points out that birth defect studies in rats
and rabbits failed to detect the develop-
mentally toxic effects of PCBs (industrial
compounds widely used in the U.S. until a
1979 ban on their manufacture), for ex-
ample, while cancer tests have missed the
hazards of substances such as asbestos, ben-
zene, and cigarette smoke, delaying con-
sumer and worker protection measures by
decades in some cases.
Cancer study results are particularly
problematic, says Stephens. Every day for
two years, animals receive the largest dose
possible that is not immediately sick-
ening, a concentration far higher
than what people would be ex-
posed to, he says. “These chem-
icals could be no problem given
in realistic doses, but when you
overwhelm the body—the liver,
the kidney—there can be a kind of
indirect toxicity just from that,”he says.
Interpretation of the results also poses
problems, Stephens notes. “Some animals
are going to get cancer just because animals
Most rodents in labs live alone in shoebox-size cages with nothing to do; experiments may leave them in near


































































































































































































get cancer. So what levels should raise
alarm? What you find is that at the end of
the day, there is a gross characterization
where unless results are at one end of the
extreme or the other, you typically don’t
have high confidence that people are going
to react the same way.”
Out of 3,000 cancer tests in animals, 53
percent identified the tested substances—
some as common as acetaminophen—as
carcinogenic, says Thomas Hartung, di-
rector of the Center for Alternatives to
Animal Testing at JohnsHopkins University.
Hartung says this figure is likely 10 times
higher than it would be in humans, probably
because rats aremuchmore prone to tumors.
Animal testing of pharmaceuticals has
also provided dubious information.Ninety-
two percent of drugs that pass the animal
testing stage are ultimately abandoned, ac-
cording to a 2004 Food and Drug Adminis-
tration report. Of these, 60 percent caused
adverse effects in human clinical trials that
weren’t predicted in animals; the other 40
percent were found to be ineffective in
people, despite promising results in animals.
“That’s 92 percent of drug candidates
down the drain after many years of research,
development, and investment,” says Seidle.
“It’s a tremendously high attrition rate,
which speaks very poorly of the methods
that are currently available. So for many of
the companies, animal testing is just bad for
business. It’s costing them way too much,
and in this economic climate they can’t
afford it.”
Hartung agrees. “I think that people
have learned over the last few years that the
‘gold standard’ for what we have been doing
is not that gold. The limitations are increas-
ingly obvious,” he says. “Some of the big
companies are running into enormous
problems. They see it as the toxicology was
not always giving them the best advice.”
FINDING A BETTER WAY
With nearly 300 brands used by 3 billion
people every day, Procter & Gamble is well-
positioned to help drive change in the field.
The company has spent more than $250
million over the past 22 years on alterna-
tives, reducing its animal usage by 98 per-
cent in that time, aiding in the development
TheWay Forward: Eye Irritation
Sixty-five years after it was devised by toxicologist John Draize, a rabbit test
remains the standard animal study for measuring eye irritation caused by chemicals
and products. The test substance is put in the rabbit’s eye sac, says Martin Stephens,
vice president of animal research issues for The HSUS, “and the eyelids are held shut so
the substance can get on the cornea and all around the eye.” The eyes are rated for
irritancy as indicated by redness, ulceration, hemorrhaging, cloudiness, or blindness.
The rabbits are held for up to 21 days and then killed.
A leading alternativemethod uses the corneas of cow eyes left over from themeat
industry. The cow eye test and a similar test using chickens’ eyes have been approved
in the U.S. and Europe as alternative methods for assessing severe eye irritants or cor-
rosive materials, meaning live animals need no longer be used to test for substances
likely to cause the worst suffering. Negative test results using these methods, however,
require further tests in rabbits, and no alternative methods have yet been approved for
evaluating milder irritants.
But hope is on the horizon. In one recent victory, The HSUS helped ensure that
germ-killing cleaning products no longer need to be tested on rabbits’ eyes to deter-
mine safety labels in the U.S. “I think
the Draize eye test is almost history,”
says Thomas Hartung, director of the
Center for Alternatives to Animal
Testing at Johns Hopkins University,
which formed in 1981 largely in re-
sponse to public outrage over the test.
“And people are waiting for this—
nobody likes this assay. We don’t have
an answer to all the possible applica-
tions, but … give it a year or two.”
Full-body restraints hold rabbits during the application
of a test substance to their eyes—in some cases, for
more than 24 hours following the procedure.
A rabbit endures
an eye irritancy test.
24 allanimals SEPTEMBER | OCTOBER 2009
TheWay Forward: Skin Irritation and Corrosion
Testing for skin irritation and corrosion closely parallels the Draize eye test.
The test substance is applied to a rabbit’s shaved skin, then removed after four hours.
The skin is observed for up to 14 days.
Today this test can be fully replaced with what is known as a nonanimal tiered ap-
proach. First, a proven nonanimal test is carried out for skin corrosion, or irreversible
tissue destruction. One such test consists of a glass vial capped by an artificial skin-like
membrane; when a corrosive substance destroys the barrier, the fluid in the vial changes
color or texture. This and other skin model
tests have been accepted in the U.S. and
Europe as alternatives to the rabbit test.
If a substance is shown to be noncor-
rosive, a second test for milder irritation is
still necessary, for which several high-tech,
three-dimensional human skin models
have been developed. Thanks largely to
the work of Humane Society International
as part of its Hop to It, Europe! campaign to end animal use in skin irritation testing, the
EU recently accepted three such models—a victory that “we project, given the testing
requirements for chemicals alone, will probably save upwards of 30,000 rabbits annu-
ally,” says HSI research and toxicology director Troy Seidle. The HSUS anticipates global
acceptance of these human skin models within the next year.
of 50 alternative methods, and completing
more than 400 publications on the topic,
says Len Sauers, vice president for product
safety and regulatory affairs. P&G also
funds jointly with The HSUS alttox.org, a
website devoted to the advancement of
nonanimal methods, and partners with The
HSUS to give financial awards to encourage
alternatives development.
The investment stems from a commit-
ment to animal welfare and a recognition
that alternatives are often more objective
and efficient, Sauers says. For example, a
previously standard version of an allergy
test involved applying substances to the skin
of guinea pigs, observing the effects over a
month, and then subjectively grading the
response. An alternative test conducted on
mice uses fewer animals and causes less suf-
fering; researchers measure the proliferation
of a certain cell type, says Mark Lafranconi,
a P&G toxicologist.“So we’re not waiting to
see the expression of the disease; we’re
seeing a subtle or biochemical change that
occurs,” he says. “And it becomes much
more objective, much more refined. It also
can be conducted in about a third of the
time of the original test.”
Through its work with P&G and other
corporations, The HSUS is advancing alter-
native methods based on the“Three Rs” ap-
proach of replacing, reducing, and refining
animal use. Some of these alternatives use
human tissues or animal cell lines grown in
a test tube or computer models that map
cellular structures and processes. Other
strategies involve conducting tests on ani-
mals only when negative results are ob-
tained in the nonanimal test, prioritizing
the more toxic and common chemicals for
testing, and eliminating redundant or need-
less testing requirements.
The HSUS is pressing government
agencies and politicians on both sides of the
Atlantic to become more accepting of
animal-free alternatives in regulatory pro-
grams for drugs, pesticides, and other chem-
icals—a tough task in a sometimes hostile
environment, says Seidle. “You have to con-
vince government regulators that Door No.
2 is just as good, if not better than,Door No.
1 that they’ve been using for decades—in
some cases for most of their careers—and
often can’t be bothered changing.”Advocates
must also persuade authorities to accept
methods validated in other countries so that
multinational companies don’t have to
follow a maze of regulations.
In spite of the red tape, progress is
being made, however incrementally. To
date, nearly 50 alternative tests have been
declared scientifically valid. Acceptance of
alternative techniques is becoming main-
stream, says Hartung, as evidenced by his
recent invitation from a leading science
Toxicology at theNational Institutes of Health Chemical Genomics Center revolves around assessing compounds using
trays with tiny cell-filled wells. Robots can perform thousands of tests in an afternoon. Experiments are conducted at
several dosage levels and examine multiple cell effects to ensure precision and accuracy, says Sunita Shukla, a post-
doctoral fellow whose position is funded in part through an alternatives award from The HSUS and Procter & Gamble.






























































































journal to reflect on the future of toxicology.
Hartung acknowledges the success of
animal advocates in challenging the status
quo, and Stephens notes that after decades
of being shut out of influential decision-
making and advisory bodies, animal welfare
organizations finally have a role in many of
them. For one, The HSUS’s international af-
filiate, HSI, has been a leader in advancing
acceptance of alternatives through the
global Organisation for Economic Co-op-
eration and Development. “We’re seen as
legitimate players,” Stephens says. “We’re
not just standing outside the castle, lobbing
stuff over the parapet—we’re engaging on
science policy issues.”
TOXICITY TESTING
FOR THE 21ST CENTURY
In Europe, the push for alternatives has long
been driven by cultural views on animal
protection, as well as laws such as a 1986 re-
quirement that nonanimal tests be used
wherever available and a 2003 EU directive
phasing in a ban on animal testing of cos-
metics products and their raw ingredients.
Even a large-scale EU chemical testing pro-
gram has pushed corporations and govern-
ments to invest in nonanimal tests, says
Stephens.
Oneof themost notorious animal experiments, the Lethal
Dose 50 Percent or “LD50” test involves giving animals a substance
through force-feeding, inhalation, and/or skin applications and
measuring the amount that kills half the test subjects. Rats, mice,
and rabbits are mostly used as surrogates for humans, while tests
on fish and birds are carried out to examine potential hazards to
wildlife populations.
LD50-type studies have evolved since their creation in 1927
and are today referred tomore generally as “acute toxicity” studies.
Thomas Hartung, director of the Center for Alternatives to Animal
Testing at Johns Hopkins University, notes that the test “is dramat-
ically losing importance.” Test group sizes have been reduced from
150 in the 1970s to 40 or fewer today. In some parts of the world,
such as the U.K., regulators now accept nonlethal signs of toxicity
instead of death.
But this modest animal welfare refinement has been imple-
mented only for force-feeding tests; for inhalation and skin studies,
lethal poisoning remains the objective. Furthermore, for pesticides
and each of their raw ingredients, authorities in the U.S. and
other countries require acute toxicity studies to be carried out
by all three methods. Humane Society International research
and toxicology director Troy Seidle is working with progressive
corporate and government scientists in Europe to challenge
such testing requirements “in the hopes of sparing tens of
thousands of animals each year from one of the cruelest fates
imaginable,” he says.
Alternativemethods are also being developed; one promising
approach uses death of cells in a test tube as a starting point for
predicting the dose that kills half the animals. Martin Stephens,
HSUS vice president of animal research issues, hopes these alter-
natives will eventually be supplanted by wholly cell-based
methods, as well as the use of emerging technology to examine
what causes toxicity in humans and predict “what would be the
lethal dose in a person in a much more sophisticated way.”
TheWay Forward: Acute Toxicity/Lethal Dose 50 Percent
Workers at the Institute for In Vitro Sciences assess products for eye irritation using cow corneas left over from themeat
industry and kept in cubelike chambers—amethod preferable to using live animals. After a test substance is applied,
the corneas are measured for opacity; the cloudier the cornea and the more the outermost tissues swell, the greater
the irritation. A second test is performed using dye to measure the effects of irritation on the cornea’s permeability.
These precise assessments replace the subjective Draize test on rabbits, where researchers visually determine the
level of irritation and assign a score.
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In the nonanimal skin irritation test developed by Massachusetts-based MatTek Corporation, test substances are applied to tiny pieces of MatTek’s EpiDerm™ human skin-like
tissue for an hour. After the substances are removed, the tissues are incubated for 42 hours before being mixed with a special chemical. When the mixture’s color intensity is
measured in a spectrophotometer, dark purple indicates the test substance will not be irritating to human skin.
A government alternatives center was
established in 1991 as the cornerstone of a
well-funded strategic approach in Europe.By
comparison, it wasn’t until 1997 that theU.S.
government—long considered underfunded
and scattered in its Three Rs efforts—estab-
lished an alternatives agency,which has since
been criticized for sluggish movement on
approving nonanimal tests. And although
California, New Jersey, and New York have
passed laws requiring the use of available
alternatives, no such federal law exists.
But recent developments have vaulted
the U.S. to the forefront of the field. In 2004,
the Chemical Genomics Center at the Na-
tional Institutes of Health began applying a
technology borrowed from the pharmaceu-
tical industry to the testing of compounds.
Using high-speed automated robots
and, instead of animals, cells and isolated
molecular targets, the technique turns tradi-
tional toxicology on its head. Rather than
observing effects in animals and trying to
extrapolate the results to people, the tech-
nology attempts to uncover the processes in
the human body that lead to toxicity and to
pinpoint the chemicals that trigger them.
The shift is expected to not only drastically
reduce animal testing but produce results
that will better serve public health and safety.
Center director Dr. Chris Austin says
the new science will enable researchers to
rapidly assess tens of thousands of com-
pounds, an impossible outcome with ani-
mal testing. But the project is exploring
uncharted territory, he notes, and scientists
must prove that results obtained in cells
are relevant to those that occur in the
entire body.
A 2007 report commissioned by the
Environmental Protection Agency formal-
ized the new approach as the way of the
future. Toxicity Testing in the 21st Century:
A Vision and a Strategy calls for limiting
animal testing to situations where new
alternatives are not yet ideal—and predicts
that such targeted animal testing will even-
tually diminish. Early last year, three federal
agencies signed an agreement to cooperate
in the research, development, and validation
of the new strategy.
Stephens, who served on the com-
mittee that produced the report, estimates
that the effort will require an investment of
$2 billion over 10 years. For its part, The
HSUS is lobbying for federal funding,
encouraging conversation through forums
such as alttox.org, and pushing scientists,
regulators, and industry to work together.
“Some people will say, ‘This is a generation
away; talk to us when you’re finished,’ ”
Stephens says. “But we’re trying to en-
courage the development of pilot programs
that will demonstrate pieces of the ap-
proach, so that people won’t be so daunted
by the prospect of the approach having to
conquer the whole field at once.”
Austin notes that the Tox 21 project has
enjoined groups that have not always seen
eye-to-eye on the issue of animal use in tox-
icity testing:“We are working very closely to-
gether to meet a common goal in a very
cooperative, respectful, collegial way,” he
says. “Whenever you have groups of human
beings who have seen themselves as adver-
saries … working together for a common
goal, for the common good, that ought to be
celebrated. That’s what this represents.”
Cruelty-Free
Shopping
Many companies conduct animal
testing on cosmetics, personal care,
and household products to satisfy
safety requirements, though it is not
specifically mandated for thesema-
terials in the U.S. The HSUS is a
founding member of the Coalition
for Consumer Information on Cos-
metics, which maintains a list of
products where no animal testing
was used in any phase of develop-
ment by the company or its labora-
tories or suppliers.
TO FIND OUT which products
are on the list—identified on their
packaging by the CCIC’s leaping
bunny logo—and to order a free
pocket-sized shopping guide,
visit leapingbunny.org.
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